Targeting disease with benzoxazoles: a comprehensive review of recent developments

被引:8
作者
Abdullahi, Abdulrahman [1 ]
Yeong, Keng Yoon [2 ]
机构
[1] Univ Gadjah Mada, Fac Math & Nat Sci, Dept Chem, Sekip Utara 55281, Yogyakarta, Indonesia
[2] Monash Univ Malaysia, Sch Sci, Jalan Lagoon Selatan, Bandar Sunway 47500, Selangor, Malaysia
关键词
Benzoxazoles; Bioactivity; Molecular targets; Rational drug design; MICROWAVE-ASSISTED SYNTHESIS; SELECTIVE COX-2 INHIBITORS; APOPTOSIS INDUCERS DESIGN; MOLECULAR DOCKING; BIOLOGICAL EVALUATION; VEGFR-2; INHIBITORS; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL EVALUATION; SYNTHETIC STRATEGIES; DERIVATIVES DESIGN;
D O I
10.1007/s00044-024-03190-7
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Benzoxazole is an attractive scaffold in medicinal chemistry due to its diverse biological applications. From 2016 to 2023, a plethora of benzoxazole derivatives have been synthesized and evaluated for their pharmacological activities but a review on this topic was found lacking. This review thus aims to fill the gap and discusses the pharmacological activities of the synthesized derivatives, emphasizing their interactions with key biological targets implicated in diseases such as cancer, diabetes, pain, inflammation, and cardiovascular disorders. Relevant works were selected mainly from databases such as PubMed and Google Scholar to offer a comprehensive overview of derivatives with promising bioactivities. The limitations pertinent to some derivatives, such as poor in vitro or in vivo activities, were highlighted, while their prospects in drug discovery was discussed.
引用
收藏
页码:406 / 438
页数:33
相关论文
共 160 条
[51]   Biological activity and ADME/Tox prediction of some 2-substituted benzoxazole derivatives [J].
Foto, Fatma Zilifdar ;
Foto, Egemen ;
Ertan-Bolelli, Tugba ;
Yildiz, Ilkay .
BIOORGANIC CHEMISTRY, 2022, 123
[52]   Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort study [J].
Fox, Kathleen M. ;
Wang, Li ;
Gandra, Shravanthi R. ;
Quek, Ruben G. W. ;
Li, Lu ;
Baser, Onur .
BMC CARDIOVASCULAR DISORDERS, 2016, 16
[53]   VEGF as a potential target in lung cancer [J].
Frezzetti, Daniela ;
Gallo, Marianna ;
Maiello, Monica R. ;
D'Alessio, Amelia ;
Esposito, Claudia ;
Chicchinelli, Nicoletta ;
Normanno, Nicola ;
De Luca, Antonella .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (10) :959-966
[54]   A benzoxazole derivative as an inhibitor of anaerobic choline metabolism by human gut microbiota [J].
Gabr, Moustafa T. ;
Machalz, David ;
Pach, Szymon ;
Wolber, Gerhard .
RSC MEDICINAL CHEMISTRY, 2020, 11 (12) :1402-1412
[55]   In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs [J].
Gagic, Zarko ;
Ruzic, Dusan ;
Djokovic, Nemanja ;
Djikic, Teodora ;
Nikolic, Katarina .
FRONTIERS IN CHEMISTRY, 2020, 7
[56]   Multi-Kinase Inhibitors [J].
Garuti, Laura ;
Roberti, Marinella ;
Bottegoni, Giovanni .
CURRENT MEDICINAL CHEMISTRY, 2015, 22 (06) :695-712
[57]   Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents? [J].
Gasparini, G ;
Longo, R ;
Sarmiento, R ;
Morabito, A .
LANCET ONCOLOGY, 2003, 4 (10) :605-615
[58]   Inflammatory resolution: New opportunities for drug discovery [J].
Gilroy, DW ;
Lawrence, T ;
Perretti, M ;
Rossi, AG .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (05) :401-416
[59]   Benzoxazoles, Phthalazinones, and Arylurea-Based Compounds with IMP Dehydrogenase-Independent Antibacterial Activity against Francisella tularensis [J].
Gorla, Suresh Kumar ;
Zhang, Yan ;
Rabideau, Meaghan M. ;
Qin, Aiping ;
Chacko, Shibin ;
House, Amanda L. ;
Johnson, Corey R. ;
Mandapati, Kavitha ;
Bernstein, Hannah M. ;
McKenney, Elizabeth S. ;
Boshoff, Helena ;
Zhang, Minjia ;
Glomski, Ian J. ;
Goldberg, Joanna B. ;
Cuny, Gregory D. ;
Mann, Barbara J. ;
Hedstrom, Lizbeth .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (10)
[60]   Multitarget Approaches against Multiresistant Superbugs [J].
Gray, Declan Alan ;
Wenzel, Michaela .
ACS INFECTIOUS DISEASES, 2020, 6 (06) :1346-1365